BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22256846)

  • 1. Dexrazoxane treatment of doxorubicin extravasation injury in four dogs.
    Venable RO; Saba CF; Endicott MM; Northrup NC
    J Am Vet Med Assoc; 2012 Feb; 240(3):304-7. PubMed ID: 22256846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
    Conde-Estévez D; Saumell S; Salar A; Mateu-de Antonio J
    Anticancer Drugs; 2010 Sep; 21(8):790-4. PubMed ID: 20671512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
    Frost A; Gmehling D; Azemar M; Unger C; Mross K
    Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Totect: a new agent for treating anthracycline extravasation.
    Schulmeister L
    Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.
    Kicenuik KS; Northrup NC; Clarke DM; Bazzle LJ
    Can Vet J; 2018 Oct; 59(10):1079-1084. PubMed ID: 30510312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment.
    Vos FY; Lesterhuis WJ; Brüggemann RJ; Graaf WT
    Anticancer Drugs; 2012 Jan; 23(1):139-40. PubMed ID: 21934601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anthracycline extravasation with dexrazoxane.
    Langer SW; Sehested M; Jensen PB
    Clin Cancer Res; 2000 Sep; 6(9):3680-6. PubMed ID: 10999761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
    Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BET 3: emergency management of anthracycline extravasation.
    Drake D
    Emerg Med J; 2012 Sep; 29(9):777-9. PubMed ID: 22903427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of dexrazoxane for the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):573-6. PubMed ID: 22143379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
    Kane RC; McGuinn WD; Dagher R; Justice R; Pazdur R
    Oncologist; 2008 Apr; 13(4):445-50. PubMed ID: 18448560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.
    Muthuramalingam S; Gale J; Bradbury J
    Int J Clin Pract; 2013 Mar; 67(3):244-9. PubMed ID: 23409691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
    Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE
    N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing.
    El-Saghir N; Otrock Z; Mufarrij A; Abou-Mourad Y; Salem Z; Shamseddine A; Abbas J
    Lancet Oncol; 2004 May; 5(5):320-1. PubMed ID: 15120669
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient.
    FitzPatrick WM; Dervisis NG; Kitchell BE
    Vet Comp Oncol; 2010 Dec; 8(4):273-82. PubMed ID: 21062409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of doxorubicin extravasation with intravenous dexrazoxane in a cat.
    Mahoney JA; Bergman PJ; Camps-Palau MA; Hull TL
    J Vet Intern Med; 2007; 21(4):872-3. PubMed ID: 17708413
    [No Abstract]   [Full Text] [Related]  

  • 20. Dexrazoxane for anthracycline extravasation.
    Langer SW
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1081-8. PubMed ID: 18028016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.